Author: GlobeNewswire

STOUGHTON, Mass., March 22, 2022 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL) (“Collegium”) today announced that it has completed…

REDWOOD CITY, Calif., March 22, 2022 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that Coherus plans to…

Regulated information — Inside information March 22, 2022 Breda, the Netherlands — argenx SE (Euronext & Nasdaq: ARGX), a global immunology…

YAVNE, Israel, March 22, 2022 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD) (“MediWound”), a biopharmaceutical company that develops, manufactures and commercializes novel,…

Conference call begins today at 4:30 p.m. Eastern timeBASKING RIDGE, N.J., March 22, 2022 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc.…

SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology…

EMERYVILLE, Calif., March 22, 2022 (GLOBE NEWSWIRE) — Biotechnology company Zymergen Inc. (“Zymergen” or the “Company”), today reported preliminary financial…

ROCKVILLE, Md., March 22, 2022 (GLOBE NEWSWIRE) — Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics…

SAN DIEGO, Calif., March 22, 2022 (GLOBE NEWSWIRE) — Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on…

BOSTON and LOUISVILLE, Ky., March 22, 2022 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy…